More Biosimilars Marketed in Germany, Switzerland Than U.S.

FRIDAY, Dec. 2, 2022 -- More biosimilars have been marketed in Germany and Switzerland than in the United States, but uptake has increased over time in all countries, according to a study published online Dec. 2 in JAMA Network Open. David L. Carl,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news